Clinical model predicting recurrence after fertility-sparing treatment for endometrial cancer and atypical hyperplasia: Development and external validation
World Journal of Clinical Oncology · 10.11.2026
DOI: 10.5306/wjco.127302 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Clinical Oncology, online erschienen am 10.11.2026. Verfasst von Ze-Rui Xiao und 12 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Xiao, Z., Shen, S., Bo, L., Liu, S., Feng, Y., Zhai, Z., Lai, J., Feng, X., Liu, S., Luo, X., Wang, J., Li, X., & Wang, Y. (2026). Clinical model predicting recurrence after fertility-sparing treatment for endometrial cancer and atypical hyperplasia: Development and external validation. World Journal of Clinical Oncology. https://doi.org/10.5306/wjco.127302
Vancouver
Xiao Z, Shen S, Bo L, Liu S, Feng Y, Zhai Z, et al. Clinical model predicting recurrence after fertility-sparing treatment for endometrial cancer and atypical hyperplasia: Development and external validation. World Journal of Clinical Oncology. 2026. doi:10.5306/wjco.127302
BibTeX
@article{Xiao2026,
author = {Xiao, Ze-Rui and Shen, Si-Cheng and Bo, Lin-Lin and Liu, Si-Jia and Feng, Yi-Fan and Zhai, Zhuo-Yu and Lai, Jin and Feng, Xiao-Tong and Liu, Si-Ru and Luo, Xue-Zhen and Wang, Jian-Liu and Li, Xing-Chen and Wang, Yi-Qin},
title = {Clinical model predicting recurrence after fertility-sparing treatment for endometrial cancer and atypical hyperplasia: Development and external validation},
journal = {World Journal of Clinical Oncology},
year = {2026},
doi = {10.5306/wjco.127302}
}
EUVIMED